Medical Test to Know Gender of a Baby Within 1 Month
Exam Tin Tell Fetal Sexual activity at 7 Weeks, Study Says
A simple blood exam that can determine a baby's sexual practice equally early equally seven weeks into pregnancy is highly authentic if used correctly, a finding that experts say is likely to lead to more widespread use by parents concerned about gender-linked diseases, those who are merely curious and people because the more than ethically controversial step of selecting the sexual practice of their children.
The entreatment of the examination, which analyzes fetal Deoxyribonucleic acid establish in the mother's claret, is that it can constitute sex weeks earlier than other options, like ultrasound, and is noninvasive, unlike amniocentesis and other procedures that behave modest risks of miscarriage. The finding came in a study published online Tuesday in The Journal of the American Medical Association.
The tests take been bachelor to consumers in drugstore chains and online for a few years, but their employ has been limited, partly because their accuracy was unclear. One visitor, which guaranteed 99.nine percent accuracy as early on as five weeks into pregnancy, filed for bankruptcy afterwards a lawsuit by scores of women whose tests showed the opposite sexual activity of the babe they concluded up having.
European doctors now routinely apply the tests to help expectant parents whose offspring are at risk for rare gender-linked disorders determine whether they need invasive and costly genetic testing. For example, Duchenne muscular dystrophy affects boys, but if the fetus is not the at-adventure sex, such tests are unnecessary. But doctors in the United States by and large have not prescribed the tests because they are unregulated and medical labs are non withal federally certified to utilise them.
That and other aspects of the pregnancy landscape could change as a issue of the new written report. The journal study analyzed reams of enquiry on fetal Deoxyribonucleic acid tests — 57 studies involving nigh 6,500 pregnancies — and found that carefully conducted tests could determine sexual practice with accuracy of 95 percent at seven weeks to 99 pct at 20 weeks.
The study "has wide-reaching implications," said Dr. Louise Wilkins-Haug, director for maternal-fetal medicine and reproductive genetics at Brigham and Women's Hospital in Boston, who was not involved in the enquiry. "Individuals need to be conscientious" to ensure that companies use rigorous laboratory procedures and back up accuracy claims with data, she added.
One potential worry is that women might abort fetuses of an undesired sex activity. Several companies do not sell tests in Red china or India, where boys are prized over girls and fetuses institute to be female accept been aborted. While sex option is not considered a widespread objective in the U.s.a., companies say that occasionally customers expressed that interest, and have been denied the test. A recent study of third pregnancies in the journal Prenatal Diagnosis found that in some Asian-American groups, more boys than girls are born in ratios that are "strongly suggesting prenatal sex choice," the authors said.
At least i company, Consumer Genetics, which sells the Pink or Blue test, requires customers to sign a waiver saying they are not using the test for that purpose. "We don't want this technology to be used as a method of gender selection," said the company'southward executive vice president, Terry Carmichael. Sex-determination tests are part of a new frontier of fetal Deoxyribonucleic acid testing, which can exist used to determine paternity and claret type, and is being used to develop early screening tests for genetic diseases or disorders like Down syndrome.
The new study constitute that to be reliable, the sexual practice-conclusion tests had to exist performed afterwards at to the lowest degree 7 weeks of gestation. Most tests that were highly accurate were conducted on a female parent's claret, not urine. And sure rigorous laboratory procedures had to exist followed. For the claret tests, women prick their fingers and ship blood samples to labs. If the Y chromosome is detected, the fetus is male. Absence of a Y chromosome would probably hateful the fetus is female, merely could mean that fetal Deoxyribonucleic acid was not found in that sample.
The tests are not regulated by the Food and Drug Administration because they are not used for medical purposes, a spokeswoman said, merely the agency is investigating the explosion of home genetic tests like these and genome-sequencing kits.
Paradigm 
Dr. Diana Bianchi, executive director of the Female parent Infant Research Institute at Tufts Medical Center in Boston and the lead author of the sexual practice-determination report, said, "A very of import aspect of the report is how this advances prenatal intendance."
But there are potential concerns too, she said, including that women may spend more than $250 for the tests when they don't take insurance for prenatal care. A typical blood test like Pink or Blueish, for example, costs $25 for the kit. Lab fees and shipping costs, which vary, bring the full expense to $265 to $330.
Dr. Bianchi is conducting another study to "try to find out why people are buying these things and what are the consequences," she said. "Information technology'due south very important to educate health intendance providers that meaning women are buying these tests."
Another type of examination not studied by the researchers has become pop because it is cheaper and can be done at domicile. These tests analyze hormones in women's urine, a method that several experts said has not been studied equally rigorously as Deoxyribonucleic acid. Rebecca Griffin, a founder of the biggest seller, Intelligender, said two contained studies found it 90 percent authentic at x weeks.
Another visitor, TrovaGene, has developed a Deoxyribonucleic acid test using urine, which, according to Gabriele Cerrone, TrovaGene's co-founder and director, is 95 percent accurate at predicting boys at vii weeks, and 88 pct authentic at predicting girls. TrovaGene is besides developing a test for Down syndrome.
Nigh Dna tests on the market apply blood.
Raylene Lewis, 34, of Higher Station, Tex., had a frustrating experience with a now-defunct company, Acu-Gen, which guaranteed 99.nine percent accurateness with its blood tests. In 2005, she was told she was having a male child, and she chose a name, bought boy clothes and told everyone. When an ultrasound revealed she was conveying a girl, "I was absolutely shocked," she said. She was not unhappy, she said, just "it was similar the baby boy disappeared."
When the Lewises complained to Acu-Gen'due south president, they were told, "We are very sure that genetically yous are having a male person," she said, reading a transcript of the conversation, which they recorded. The official suggested that the baby might be "what a baby girl looks like on the outside," merely that "we're giving y'all the results on the inside."
Ms. Lewis, who sued Acu-Gen, said she ultimately received a refund. Lawyers for Acu-Gen could not be reached for annotate.
The Pink or Blue examination, which claims 95 percentage accuracy at vii weeks and gives refunds for wrong results, appears to meet the standards described in the new study.
Chelsea Wallace, 23, of Okeechobee, Fla., was thrilled early this year when the examination she took at seven weeks said she was having a boy, a event confirmed weeks later on by ultrasound. Ms. Wallace, who has a 3-yr-old daughter, said she also would have been happy with a girl, just that since she and her fiancé could not hold on a boy's name, finding out early gave them time to cull the proper noun Layton. It also helped her programme, she said.
"As presently every bit I found out I was pregnant," said Ms. Wallace, whose son is due in September, "I wanted to know what I was having."
Source: https://www.nytimes.com/2011/08/10/health/10birth.html
0 Response to "Medical Test to Know Gender of a Baby Within 1 Month"
Post a Comment